Join Dr. TJ Slavin of Ambry Genetics and Jennifer Hoskovec of BillionToOne to explore breakthroughs in whole genome sequencing, rare disease diagnosis, and noninvasive prenatal testing live from NSGC 2026.
All in Interview
Join Dr. TJ Slavin of Ambry Genetics and Jennifer Hoskovec of BillionToOne to explore breakthroughs in whole genome sequencing, rare disease diagnosis, and noninvasive prenatal testing live from NSGC 2026.
Renowned gene-editing expert Dr. Kiran Musunuru explores CRISPR’s journey from edited embryos in China to the personalized treatment he helped develop for Baby KJ.
With 4 precision treatments now approved or in late-stage development, we explore how the expanding achondroplasia treatment landscape could shape growth, body proportionality, function, and family decision-making.
Dr. Jennifer Brown and her daughter Lillian Isabella explore the realities of PKU, from food and family life to mental health and independence.
Pioneering prenatal genetics researcher Dr. Diana Bianchi shares what the IDENTIFY study is revealing about unexpected cancer signals in cfDNA screening.
Genetic counselor Amy Patterson kicks off our three-part hypophosphatasia (HPP) series explaining the disorder and diagnosis.
Melanie Hardy and Amy Shikany take listeners inside the American Board of Genetic Counselor’s (ABGC) board exam and explain how to prepare with the latest 2026 resources.
Our PKU series kicks off with Sarah Chamberlin and Ryan Miller, sharing the journey from newborn screening result to diagnosis, treatment, and family support.
Baylor Genetics’ Dr. Christine Eng and Chris Sands explore the power of whole genome sequencing when paired with multi-omic technology, like long-read sequencing, optical genome mapping, and RNA sequencing.